πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine β€” grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≀24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months β€” use filters for patent-cliff planning.

Page 7 of 15

  1. US 10590082

    N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10590093

    1,2,4-oxadiazole derivatives as immunomodulators

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10584103

    Small molecule agonists of neurotensin receptor 1

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10577406

    FKBP-L polypeptides and uses in angiogenesis-mediated disorders

    Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10570128

    Agonists of the apelin receptor and methods of use thereof

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10556890

    Heteroaryl compounds and methods of use thereof

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10556897

    Protein kinase inhibitors

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10548883

    Benzotriazole-derived Ξ± and Ξ²-unsaturated amide compound used as TGF-Ξ² RI inhibitor

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10544188

    Inhibitor of apoptosis protein (IAP) antagonists

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10532986

    Cyclic compound acting as PDE4 inhibitor

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10519133

    Vinyl compounds as FGFR and VEGFR inhibitors

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10508103

    Benzimidazole-linked indole compound acting as novel divalent IAP antagonist

    Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10500246

    Compositions for delivery to and treatment of atherosclerotic plaques

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10500175

    Compositions and methods for the treatment of cancer

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10487088

    Tricyclic compound serving as immunomodulator

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10485796

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10479786

    Protein kinase inhibitors

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10472385

    Triterpene-glycosides as sweeteners or sweetener enhancers

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10471035

    Compositions and methods for using esters of meroterpenes and of other resveratrol analogues

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10472357

    Triazolopyridine compounds and methods for the treatment of cystic fibrosis

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10456439

    NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10420705

    Container assembly

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10414771

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10377695

    Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10370366

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10370333

    Sulfonamide compounds and uses as TNAP inhibitors

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10369145

    Coumarin derivatives and methods of use in treating hyperproliferative diseases

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10364258

    Heteroaryl inhibitors of PDE4

    Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10357453

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10336732

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10335440

    Direct-fed microbials

    Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10322161

    EPHA4 cyclic peptide antagonists for neuroprotection and neural repair

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10322129

    Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10316371

    Screening methods for identifying specific Staphylococcus aureus inhibitors

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10308617

    Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10300134

    Vaccine formulations and methods of preparation and use thereof

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10300074

    Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10291197

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10280160

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10280218

    Antibodies binding to BMP4, and uses thereof

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10280229

    Linkers and their application towards ADC

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10272074

    Inhibitors of glucocorticoid receptor translocation

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10266549

    ULK1 inhibitors and methods using same

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10231903

    Pharmaceutical compounding methods and systems

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10227362

    Anti-pulmonary tuberculosis nitroimidazole derivative

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10226420

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10221195

    Pyridine compounds

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10214531

    Substituted amino triazoles, and methods using same

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.